Vertex Pharmaceuticals Incorporated vs Zillow Group Inc Class C — how do they compare? Vertex Pharmaceuticals Incorporated trades at $478.06 (market cap $121.95B), while Zillow Group Inc Class C trades at $31.8 (market cap $7.54B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 16.2× Zillow Group Inc Class C's market cap, and Vertex Pharmaceuticals Incorporated is trading nearer its 52-week high, Zillow Group Inc Class C nearer its low. Which is the better fit depends on your goals.
| VRTX | Z | |
|---|---|---|
Market Cap | $121.95B | $7.54B |
Sector | Health | Media |
52-Week High | $529.59 | $90.35 |
52-Week Low | $366.54 | $29.41 |
Enterprise Value | $116.69B | $7.19B |
Trailing returns across standard periods
Latest headlines on both assets
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →